Mark For: TIMLOZE® trademark registration is intended to cover the categories of
Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 87698393 |
Registration Number | 1387455 |
Mark Literal Elements | TIMLOZE |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | TRADEMARK |
Register | PRINCIPAL |
Current Location | INTENT TO USE SECTION 2018-06-12 |
Basis | 1(b) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | Yes |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Sarah Anne Keefe |
Attorney Docket Number | 105231.184.6 |
Law Office Assigned | L80 |
Employee Name | BUSH, KAREN K |
2017-11-27 | Application Filed |
2018-04-17 | Published |
2018-04-17 | Published for Opposition |
2018-06-12 | Location: INTENT TO USE SECTION |
2019-12-04 | Status: Live/Pending |
2019-12-06 | Transaction Date |
2020-12-03 | Status: A fifth request for extension of time to file a Statement of Use has been granted. |
Party: | ![]() |
Address | 950 Winter Street Waltham, MASSACHUSETTS UNITED STATES 02451 |
Legal Entity Type | Corporation |
Legal Entity State | DELAWARE |
![]() | JPEG | 2017-11-27 |
![]() | MULTI | 2017-11-27 |
![]() | XML | 2018-03-09 |
![]() | MULTI | 2018-03-13 |
![]() | XML | 2018-03-28 |
![]() | XML | 2018-03-28 |
![]() | XML | 2018-04-17 |
![]() | XML | 2018-06-12 |
![]() | XML | 2018-10-01 |
![]() | XML | 2018-12-12 |
![]() | XML | 2018-12-14 |
![]() | MULTI | 2018-12-14 |
![]() | XML | 2019-06-06 |
![]() | XML | 2019-06-08 |
![]() | MULTI | 2019-06-08 |
![]() | XML | 2019-12-04 |
![]() | XML | 2019-12-06 |
![]() | MULTI | 2019-12-06 |
![]() | XML | 2020-04-02 |
![]() | XML | 2020-04-04 |
![]() | MULTI | 2020-04-04 |
![]() | MULTI | 2020-11-18 |
![]() | XML | 2020-12-04 |
![]() | MULTI | 2020-12-04 |
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations for use in the treatment of bone diseases, connective tissue diseases, inflammatory diseases, blood diseases and hormonal disorders; Pharmaceutical preparations for use in the treatment of wasting and other muscle, fat and tissue loss caused by medical disorders or aging; Pharmaceutical preparations for use in hormone therapy; Pharmaceutical preparations for use in the treatment of cardiovascular diseases, central and peripheral nervous system diseases, cancer, gynecological diseases, rheumatic diseases, urological diseases, gastroenterological diseases, infectious diseases, dermatological diseases, autoimmune diseases, blood diseases, genital diseases, endocrine diseases, intestinal diseases, internal medicine diseases; Pharmaceutical preparations for use in the treatment of alopecia; Pharmaceutical preparations for use in the treatment of cognitive disorders and mood disorders; Pharmaceutical preparations for use in the treatment of diabetes and insulin-related disorders and conditions; Pharmaceutical preparations to treat wounds and trauma
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0051 | Pharmaceutical preparations for use in the treatment of bone diseases, connective tissue diseases, inflammatory diseases, blood diseases and hormonal disorders; Pharmaceutical preparations for use in the treatment of wasting and other muscle, fat and tissue loss caused by medical disorders or aging; Pharmaceutical preparations for use in hormone therapy; Pharmaceutical preparations for use in the treatment of cardiovascular diseases, central and peripheral nervous system diseases, cancer, gynecological diseases, rheumatic diseases, urological diseases, gastroenterological diseases, infectious diseases, dermatological diseases, autoimmune diseases, blood diseases, genital diseases, endocrine diseases, intestinal diseases, internal medicine diseases; Pharmaceutical preparations for use in the treatment of alopecia; Pharmaceutical preparations for use in the treatment of cognitive disorders and mood disorders; Pharmaceutical preparations for use in the treatment of diabetes and insulin-related disorders and conditions; Pharmaceutical preparations to treat wounds and trauma |
Description | Date |
---|---|
![]() | 2020-07-06 |
![]() | 2020-01-15 |
![]() | 2020-01-15 |
Description | Date | Proceeding Number |
---|---|---|
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-12-04 | |
EXTENSION 5 GRANTED | 2020-12-03 | 74055 |
CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2020-12-03 | 74055 |
TEAS EXTENSION RECEIVED | 2020-11-18 | |
EXTENSION 5 FILED | 2020-11-18 | 74055 |
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | 2020-07-22 | |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-04-04 | |
TEAS EXTENSION RECEIVED | 2020-04-02 | |
EXTENSION 4 GRANTED | 2020-04-02 | 98765 |
EXTENSION 4 FILED | 2020-04-02 | 98765 |
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | 2020-01-29 | |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-12-06 | |
TEAS EXTENSION RECEIVED | 2019-12-04 | |
EXTENSION 3 GRANTED | 2019-12-04 | 98765 |
EXTENSION 3 FILED | 2019-12-04 | 98765 |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-06-08 | |
TEAS EXTENSION RECEIVED | 2019-06-06 | |
EXTENSION 2 GRANTED | 2019-06-06 | 98765 |
EXTENSION 2 FILED | 2019-06-06 | 98765 |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2018-12-14 | |
TEAS EXTENSION RECEIVED | 2018-12-12 | |
EXTENSION 1 GRANTED | 2018-12-12 | 98765 |
EXTENSION 1 FILED | 2018-12-12 | 98765 |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2018-10-01 | |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2018-10-01 | |
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2018-06-12 | |
PUBLISHED FOR OPPOSITION | 2018-04-17 | |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2018-04-17 | |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2018-03-28 | |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2018-03-12 | |
ASSIGNED TO EXAMINER | 2018-03-09 | 67516 |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2017-12-07 | |
NEW APPLICATION ENTERED IN TRAM | 2017-11-30 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.